KARPAS 45 Human B-cell Leukaemia cell line

Human T-Cell Leukemia cell line useful in oncology research.
Technology No. KAR-6348-19

Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.

  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    KARPAS 45 Human B-cell Leukaemia cell line.pdf
    DOWNLOAD
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Internal Research Licence - 1 Year
1-year non-exclusive licence agreement for use of the Karpas 45 Cell Line for internal research only.

Term: 12 months

Price on approval

Sign up to our newsletter

If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.